Fundraising Fox

Synlogic

OTC: SYBX

Cambridge, US · Delaware corporation · 7 known investors

synlogictx.com ↗

Synlogic develops synthetic biology-based biotherapeutics that use engineered living organisms to treat diseases. The company applies synthetic biology approaches to design programmable therapeutic candidates for patients.

BiotechDeep TechMedical Devicesin /synlogic-therapeutics@synlogic_tx

Founders & leadership

EM
Ed MathersDirector
CK
Chau KhuongDirector
BC
Bharatt ChowriraExecutive Officer
AM
Ankit MahadeviaDirector
MS
Michael SheahanExecutive Officer
PB
Peter BarrettDirector
JC
Jose Carlos Gutierrez-RamosExecutive Officer, Director
LG
Lewis GeffenExecutive Officer
PM
Paul MillerExecutive Officer
AB
Aoife BrennanExecutive Officer
NL
Nick LeschlyDirector
TS
Todd ShegogExecutive Officer

Investors · 7

Atlas VentureCambridge · $500K – $1M
NSG VenturesSingapore
Pfizer Venture Investments$5M – $20M
Sofinnova VenturesMenlo Park · $100K – $15M
Solasta VenturesBoston
New Enterprise Associates (NEA)reportedMenlo Park · $200K – $40Mvia Ed Mathers · board
OrbiMedreportedNew York · $1M – $75Mvia Chau Khuong · board

Reported raises · per SEC filings

Form D private placements
▶$42MraisedMay 2017 · 16 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Paul MillerExecutive Officer
  • Peter BarrettDirector
  • Chau KhuongDirector
  • Aoife BrennanExecutive Officer
  • Nick LeschlyDirector
  • Lewis GeffenExecutive Officer
  • Jose Carlos Gutierrez-RamosExecutive Officer, Director
  • Ed MathersDirector
  • Todd ShegogExecutive Officer
Offering amount
$42M
Amount sold
$42M
First sale
May 2017
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$17.1MraisedFeb 2016 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Ed MathersDirector
  • Chau KhuongDirector
  • Bharatt ChowriraExecutive Officer
  • Ankit MahadeviaDirector
  • Michael SheahanExecutive Officer
  • Peter BarrettDirector
  • Jose Carlos Gutierrez-RamosExecutive Officer, Director
  • Lewis GeffenExecutive Officer
Offering amount
$17.1M
Amount sold
$17.1M
First sale
Feb 2016
Incorporated
Limited Liability Company, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$13.9MraisedFeb 2016 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jose Carlos Gutierrez-RamosExecutive Officer, Director
  • Ed MathersDirector
  • Lewis GeffenExecutive Officer
  • Bharatt ChowriraExecutive Officer
  • Michael SheahanExecutive Officer
  • Peter BarrettDirector
  • Chau KhuongDirector
  • Ankit MahadeviaDirector
Offering amount
$40.6M
Amount sold
$13.9M
First sale
Feb 2016
Incorporated
Limited Liability Company, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.